Clinical Trial Update: A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) [Phase 2]

View source ↗

Summary

Phase 2 PANORAMA study evaluating TCD601 for inducing tolerance in kidney transplant recipients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• TCD601

Snippet

Sponsor: ITB-Med LLC | Conditions: Kidney Transplantation | Phase 2 | Status: TERMINATED